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A BST R AC T   
 
Aim: Hypocalcemia is a common clinical problem in critically-ill patients and it is associated with 
increased morbidity and mortality. The aim of this study was to investigate serum calcium, vitamin 
D and parathyroid hormone (PTH) levels in surviving and non-surviving septic shock patients. 
Method: Patients with septic shock criteria and who were older than 18 years of age were included, 
whereas patients with diseases influencing calcium homeostasis were excluded. Demographic and 
laboratory parameters were recorded prospectively.  
Results: 41 patients, 20 of which were male were included in the study. The median (min-max) age 
of study population was 67 (19-88) years. Frequency of hypocalcemia in the study population was 
29.2% and 68.2% according to corrected calcium and ionized calcium, respectively. On the day septic 
shock was diagnosed (day 1), median vitamin D levels of survivors and non-survivors were 8.7 ng/ml 
(4.3-30.4) and 5.3 ng/ml (1.0-21.7), respectively (p=0.05). On the same day, median PTH levels of 
survivors and non-survivors were 94 ng/L (16.9-1746) and 49 ng/L (6.6-339), respectively (p=0.042). 
Although vitamin D levels were suppressed and PTH levels were elevated in non-survivors at day 5, 
this change was not statistically significant (p=0.19 and p=0.187). 
Conclusion: Hypocalcemia is frequent in septic shock patients, whereas vitamin D levels were low 
and PTH levels were high in the diagnosis day. These results suggest that vitamin D is suppressed by 
septic shock at non-surviving patients during course of septic shock. Parathyroid hormone may be a 
marker for worse outcome in critically ill patients. 
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Introduction 
Sepsis is a clinical entity which is 
characterized by infection and cardinal signs of 
inflammation such as vasodilation, 
leukocytosis and increased microvascular 
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permeability [1-3]. The spectrum of disease 
severity can range from sepsis to septic shock 
and multi organ dysfunction syndrome. The 
rate of sepsis vary widely in literature [1]. In 
the literature, incidence of sepsis reported 
ranging from 300 to 1301 cases per 100000 
population [1, 4, 5]. Although sepsis mortality 
has declined from 40% to 20% over the last 
decades because of improved processes of care 
(e.g., earlier diagnosis, timely resuscitation 
with appropriate therapies), neuromuscular, 
metabolic, cardiovascular and renal 
complications persist and lead to impaired 
long-term worse outcomes and deteriorated 
quality of life among sepsis survivors [6-9].  
Decreased concentration of ionized calcium in 
the circulation are common in critically ill 
patients, especially patients with sepsis, major 
burns and pancreatitis [10]. Studies showed 
that hypocalcemia is associated with longer 
intensive care unit (ICU) stay and increased 
ICU mortality [11]. Hypocalcemia has been 
shown to trigger cardiac dysfunction and 
hypotension which is reversible with calcium 
replacement [12-15]. More than 50% patients' 
etiology of hypocalcemia are unknown [16-
18]. Vitamin D (25-OH-vitamin D3) 
deficiency, relative hypoparathyroidism, 
vitamin D resistance and 1-alpha hydroxylase 
deficiency are proposed mechanisms for 
hypocalcemia [10]. Animal studies showed 
that inflammatory cytokines such as 
interleukin-1 (IL-1) beta and interleukin-6 (IL-
6) up-regulates calcium sensing receptors 
(CaSRs), decreases parathyroid hormone 
(PTH) and induces hypocalcemia [10]. Gram 
negative bacterial sepsis and toxic shock 
syndrome may have elevated tumor necrosing 
factor (TNF) alpha levels that have also been 
associated with hypocalcemia [15]. Current 
theories about sepsis and progression to septic 
shock focus on dysregulation of inflammatory 
response including uncontrolled release of 
proinflammatory cytokines and tissue damage 
[8]. Recent studies showed that vitamin D has 
a pivot role in innate and adaptive immunity 
besides effects on calcium homeostasis [19]. In 
contrast to its inhibitory role in adaptive 
immunity, vitamin D is a potent activator of 
innate immune system and a natural defense 
mechanism to microorganisms [20,21]. 
Evidences accumulated in literature in last five 
years suggest that significant proportion of 
critically ill patients have low vitamin D status 
[22,23] and this situation is associated with 
increased ICU mortality [24]. 
Our primary goal was to investigate the 
correlation between hypocalcemia and 
mortality, also, find out the response of vitamin 
D and PTH to dysregulated immune system 
during the course of septic shock. 
 
Methods 
Study population  
The study was conducted in internal medicine 
intensive care unit at Hacettepe University, 
Ankara, Turkey, from September 2014 to 
January 2016. Included patients were older 
than 18 years old and diagnosed as septic 
shock according to Surviving Sepsis 
Campaign: International Guidelines for 
Management of Severe Sepsis and Septic 
Shock, 2012. Patients were excluded if they 
had a disease affecting calcium, PTH and 
vitamin D metabolism such as malignancy, 
chronic kidney disease, parathyroid disorders, 
pancreatitis, tumor lysis syndrome, 
rhabdomyolysis, renal tubular disorders and 
pregnancy. 41 patients with septic shock were 
analyzed in the study.  
 
Ethics statement 
The cross-sectional study protocol conformed 
to ethical guidelines of the 1975 declaration of 
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Helsinki and all participants or their first 
degree relatives gave written informed consent 
and willingness to participate. The ethics 
committee of Hacettepe University Hospital 
approved the study protocol (Approval date: 
23/07/2014, Project No:GO 14/400). 
 
Clinical outcomes 
Hospital electronic medical records system 
was used for baseline information such as sex, 
age, comorbidities, mechanic ventilation day 
and calculation of Acute Physiology and 
Chronic Health Evaluation (APACHE) II 
score, Sequential Organ Failure Assessment 
(SOFA) score and Charlson comorbidity 
index. The 28 days mortality rates and period 
of hospitalization in the ICU were determined 
for all patients. Also, fluid resuscitation, 
vasopressor treatment and calcium 
replacement and renal replacement treatment 
data collected during course of septic shock. 
The dose of vasopressor agents is expressed as 
the inotropic score and variables calculated as: 
(dopamine dose x 1) + (dobutamine dose x 1) 
+ (adrenaline dose x 100) + (noradrenaline 
dose x 100). All doses are expressed as 
μg/kg/min. This score has also been referred to 
as the vasopressor score or catecholamine 
index [25, 26]. 
 
Laboratory measurements 
Routine laboratory measurements and blood 
samples for biomarker (hemoglobin, white 
blood cell, platelet, creatinine, albumin, 
calcium, lactate, CRP, procalcitonin) analysis 
were obtained within the first hour of septic 
shock diagnosis. The serum for ionized 
calcium (reference range 1.15-1.3 mmol/L) 
was obtained from arterial blood gas analysis.   
Venous or arterial blood samples were 
collected directly into EDTA-containing tube 
(vitamin D) on first and fifth day of septic 
shock to measure vitamin D and PTH levels. 
The samples for vitamin D was immediately 
stored on ıce and then all samples were 
centrifuged within 30 minutes to separate out 
plasma.  All samples centrifuged 5000 rpm for 
5 minutes. Vitamin D and PTH were measured 
from the separated plasma at the same time. 
Serum level of PTH was estimated by Immuno 
Radio Metric Assay (IRMA) technique using 
Beckman Coulter (USA) and vitamin D was 
estimated by liquid chromatograph mass 
spectrometer (LC-MS) technique using 
Shımadzu LCMS-8040 (JAPAN). 
 
Statistical analysis 
Variables in the text and tables were shown as 
median (minimum- maximum). For data that 
were not normally distributed the Mann-
Whitney U test was used if only two groups 
were compared. Wilcoxon test was used to 
more than one measurement in the same group. 
Receiver operating curve (ROC) analysis were 
plotted to illustrate day 1 vitamin D and PTH 
cutoff values. 28 days survival analysis was 
performed by means of Kaplan-Meier curves. 
P values less than 0.05 were considered to 
indicate statistical significance. Analyses were 
performed with SPSS 21.0.0.1 (SPSS, IBM, 
Armonk, NY) software for Windows. 
 
Results 
We evaluated 41 septic shock patients. 
Vitamin D and PTH data at day 5 were not 
available in 9 patients because of death before 
day 5. 28 days ICU mortality rate was 51.2% 
(21). Median age of study population was 67 
(19-88) years and the median Apachee II score 
was 28 (11-45).  There is no statistically 
differences according to gender, age, sofa 
score, Apachee II score, charlson comorbidity 
index and lenght of ICU stay between survivor 
and non-survivor groups.      Table 1      shows  
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clinical characteristics of patients during the 
course of septic shock. Corrected calcium and 
ionized calcium deficiency rates in study 
population were 29.2% and 68.2% during the 
first day of septic shock. Statistically 
significance were determined between 
survivor and non-survivor groups neither 
corrected calcium nor ionized calcium during 
the course of septic shock. Baseline laboratory 
parameters of these groups are summarized in 
Table 2. The median lactate level, 
procalcitonin and C-reactive protein were 3.5 
mmol/l (1.6-16), 3.04 ng/ml (0.1-283) and 14. 
mg/dl (1.64-42), respectively. These 
parameters were not significantly different 
between two groups. Although median fluid 
replacement    during  first  6 hours   of   septic  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
shock was significantly high at survivors 
compared to non-survivors [1550 ml (510-
2600) vs. 1200 ml (450-1728), p=0.01, 
respectively], this significance did not 
determined at the end of first day of septic 
shock [3102 ml (1720-6160) vs. 2500 ml 
(1197-6147), p=0.18]. Median inotrope score 
was not statistically significant between two 
groups [16 (3-100) vs. 30 (5-170), p=0.51]. 
Calcium replacement was needed 30% of 
survivors and 57% of non-survivors. Renal 
replacement treatment (RRT) was made 20% 
of survivors and 57% of non-survivors. Both 
calcium and renal replacement were not 
statistically significant between both groups 
(p=0.13 and p=0.13) (Table 3). Median day 1 
vitamin D   level   was   significantly  higher in  
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survivor group compared to non-survivor 
group [8.7 ng/ml (4.3-30.4) vs. 5.3 ng/ml (1-
21.7), p=0.05, respectively]. Median day 5 
vitamin D level was not significantly different 
between two groups [12.3 ng/ml (2-29) vs. 5.7 
ng/ml (5-21.2), p=0.19, respectively]. While 
vitamin D levels were high in survivor group, 
median PTH level was statistically 
significantly high in non-survivor group 
compare to survivors [94 ng/L (16.9-1746) vs. 
49 ng/L (6.6-339), p=0.047]. Although higher 
median PTH level in non-survivors than the 
survivors at day 5, it failed to reach statistical 
significance [112 ng/L (47.4-680) vs. 66 ng/L 
(15-312), p=0.187, respectively] (Figure 1). In  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
the subgroup analysis , vitamin D levels 
increased in the survivor group from 8.7 ng/ml 
in day 1 to 12.4 ng/ml in day 5 (p=0.17) and in 
the non-survivor group from 5.3 ng/ml to 5.7 
ng/ml (p=0.89). Similar to vitamin D, PTH 
subgroup analysis was not statistically 
significant (p=0.07 and p=0.06) in subgroup 
analysis. Day 1 vitamin D/PTH ratio was 
similar between two groups (0.125 vs. 0.07, 
p=0.18). Day 5 vitamin D/PTH ratio of patients 
who was non-survivor, tended to fall compare 
to survivor (0.054 vs. 0.157, p=0.08) (Fıgure 
2). The area under the curve for 25(OH) D 
levels in ROC analysis at day 1 in relation to 
mortality was 0.681 (95% Cl 0.52-0.85), 
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similar to those for day 1 PTH was 0.686 (95% 
Cl 0.51-0.84). The best cutoff values for 
vitamin D and PTH 6.4 ng/ml and 87 ng/L, 
with a sensitivity of 61.9% and 57.1%, 
specificity 65% and 80%. Kaplan Meier 
survival analysis revealed that patients with 
vitamin D levels ≥ 6.8 ng/ml (median) had 
increased 28 day survival as compared to 
patients with vitamin D levels ≤ 6.8 ng/ml 
(long rank test p=0.012) (Fıgure 3, Table 4). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Discussion 
The main purpose of our study was to 
investigate hypocalcemia frequency, vitamin 
D and PTH levels and their response to 
hypocalcemia at septic shock patients. Day 1 
median vitamin D was significantly higher at 
survivors compared to non-survivors. 
Although markedly elevation of vitamin D 
status at survivors during the course of septic 
shock, it was not statistically significant.  
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Day 1 median PTH level of non-survivors was 
significantly higher than survivors. Day 5 
median PTH elevated above the normal range 
at non survivors but it was not statistically 
significant. 
Septic shock was diagnosed by using the 2012 
surviving sepsis campaign guideline [2]. 
Although it was revised at 2015 [3], septic 
shock criterias did not change. Only septic 
shock patients were included in our study. As 
a result, this revision did not affect our 
assessment. Although fluid replacement 
treatment was significantly higher at survivors 
compared to non survivors at the first six hours 
of septic shock this difference was not 
statistically significant at the first day of septic  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
shock. We used same septic shock treatment 
protocol to all patients and tried to keep central 
venous pressure (CVP) between 8-12 mm/hg 
as a recommendation of surviving sepsis 
campaign [2].  The present study showed a 
high incidence of total and ionized 
hypocalcemia in septic shock patients (29.2% 
and 68.2%) similarly to previous studies [16, 
17]. Although we did not identify the 
association between hypocalcemia and 
mortality, this relation has been demonstrated 
in previous studies [16, 27, 28]. The cohort 
study at 2011 by Egi M. et al. demonstrated 
that lower than 0.8 mmol/l ionized calcium 
levels are independent risk factor for ICU 
mortality    and   stay  of  ICU length  [29]. Our  
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study did not demonstrate this relation because 
it was not an intervention study so that calcium 
and albumin were replaced with the aim of 
keeping normal range during the hospital and 
ICU stay. Besides, small numbers of patients 
due to the exclusion of chronic kidney disease 
and malignancy may effect not to reach 
statistically significance.  
It has been suggested that hypocalcemia in 
critically ill patients might be caused by the 
resistance to the action of PTH in the kidney 
and bone. There are many previous studies 
which are demonstrated elevation of PTH is 
associated with disease severity and mortality 
[23, 30-32]. Our results support previous 
studies. The median PTH concentration at day 
1 was higher at non-survivors then survivors 
despite similar serum calcium levels and it was 
statistically significant. Although median PTH 
levels were higher at day five at non-survivors, 
it was not statistically significant. Despite 
raised PTH level was not statistically 
significant from day one to day five, survivor 
patients' median PTH levels elevated within 
normal range but non-survivor patients median 
PTH levels elevated above the normal range.  
Proposed mechanism of PTH elevation at non-
survivors are cytokine dependent receptor 
resistance, hypocalcemia, low level of vitamin 
D levels at septic shock patients and end-organ 
in responsiveness [32-35]. İn addition to these 
mechanism, half-life of PTH at plasma is under 
5 minutes and most of metabolites are removed 
by the kupffer cells and 20-30% of metabolites 
removed by renal tubules [36]. Multi organ 
failure during the course of septic shock may 
affect the PTH plasma levels.  
Although PTH elevates in critically ill patients, 
hypocalcemia may be further deepens. It 
reminds other mechanisms than PTH have role  
 
 
at this pathology. In recent studies showed that 
vitamin D has an important role at innate and  
adaptive immunity, besides calcium 
metabolism [20, 21]. The results of our study 
showed that non-survivors had statistically 
significant low baseline vitamin D 
concentration than survivors. In our study, 
similar results were obtained with the 
prospective study of Lee P et al.  [37], 
observational prospective study of Garcia-
Soler P et al.  [38] and meta-analysis of Zhang 
YP et al. [39]. In addition to these studies, we 
further evaluated the vitamin D status of 
patients during the course of septic shock.  
Although it was not statistically significant we 
showed that vitamin D levels were rised at 
survivors without any vitamin D 
supplementation. The fact that, statistical 
significance might not be achieved due to the 
small number of patients. Similar to our study, 
Alves FS et al. [24] reported that vitamin D 
level were rised at survivors during the course 
of septic shock in 51 ICU patients (26 of 
patients were septic shock and 25 of patients 
were without septic shock). But there were no 
data about mortality rates and subgroup 
analysis of survivors and non-survivors makes 
the study insufficient to determine to variation 
of vitamin D during the course of septic shock. 
In our study population vitamin D level of 6.8 
ng/ml was the best cutoff for identification of 
septic shock patients at a higher risk of death. 
The relationship between mortality and serum 
vitamin D levels in critically ill patients is a 
topic of debate in the current literature [39-43].  
Our study is in agreement with some of the 
retrospective and prospective studies in the 
literature. Moraes RB. et al. [42] suggested that 
vitamin D levels under 12 ng/ml remained an 
independent predictor of mortality at critically  
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ill patients in their cohort study. As Moraes 
RB. et al and our study,  Venkatram S. et al. 
[44] suggested vitamin D levels under 10 ng/dl 
predicted hospital mortality in 83.6 % of their 
cohort. 
Gruson D et al. suggested that 1,25 (OH)D and 
its ratio to PTH to be strongly and 
independently predict cardiovascular mortality 
in chronic heart failure [45].  On the basis of 
this study, we investigated the prognostic value 
of vitamin D/ PTH ratio at septic shock 
patients. We found neither day 1 nor day 5 
vitamin D/ PTH value statistically significant. 
We might not achieve statistically significance 
because of low number of patients or not to use 
activated vitamin D as a parameter or 
dysregulation of inflammatory response 
including uncontrolled release of 
proinflammatory cytokines and tissue damage. 
Our study has several potential limitations. 
Firstly, we had low number of patients. But it 
was a single center study and on the contrary 
of other studies at the literature about this topic 
we excluded common diseases such as 
malignancies and chronic renal failure which 
effect calcium homeostasis. On the other hand, 
it was an advantage of our study about 
evaluation of vitamin D and PTH response 
during the course of septic shock. Secondly, 
we included only septic shock patients. This 
made difficult to evaluate the day 5 vitamin D 
and PTH status of patient because of high 
mortality rates. Although this limitations, this 
cross-sectional observational study is the 
largest study in the literature, which was 
evaluated vitamin D and PTH responses during 
the course of septic shock. Thirdly, the calcium 
replacement decision of the patients was left to 
the discretion of the clinician, for this reason 
we could not evaluate the association between 
hypocalcemia and mortality rate at septic 
shock patients. Finally, logistic regression 
analysis could not performed due to the low 
number of patients. A smaller sample size in 
the present study is not enough for the drawn 
conclusion. 
 
Conclusion 
Hypocalcemia is a common problem in septic 
shock patients. This could be associated with 
suppression of vitamin D as a result of 
cytokine storm during the course septic shock. 
PTH elevation at septic shock patients in 
contrast to physiological pathways could be a 
poor prognostic factor. At this point larger 
sample size and involvement of multicentric 
trials preferably involving wider spectrum of 
critically ill patients can probably widen our 
knowledge horizon regarding the crucial role 
of vitamin D and PTH. 
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